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Abstract
We have designed to apply 2-pyridine aldoxime methiodide(PAM), considered to be a cholinesterase
reactivator in vitro, both to the laboratory rabbits poisoned by parathion and to the patients of
parathion poisoning, and obtained the following results: 1. With administration of PAM, a prompt
and complete dispersion of symptoms of the poisoning can be realized. 2. Cholinesterase activity
of red blood cell has instantly and completely recovered, and that of serum transiently. 3. The
amount of serum mucoprotein and the activity of active protein-SH-radical of serum varied in di-
rect proportion to the activity of serum cholinesterase. 4. Generally, an intravenous injection of
1g. PAM is sufficient even in the severe case and it may be increased when necessary. 5. The
ill effect has not been encountered in the PAM administration. 6. PAM exerts no influence on
the cholinesterase activity of normal blood. 7. PAM is expected to play an important role as a
prophylactic agent of alkylphosphate poisoning. From these results it seems clear that PAM is a
specific and effective antidote against alkylphosphate intoxication.
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Of many alkylphosphate compounds synthesized in past twenty years,
some have come to be used in practice, as remedies (DFP etc.) and as
insecticides (TEPP, parathion, diazinon, etc.) especially after the Second
World War10•
In Japan, parathion has been widely used as an agricultural insec-
ticide mainly on rice plant since 1952, and its use has been encouraged by
the Ministry of the Agriculture and Forestry in order to increase rice
crop. It is a concensus opinion that parathion as an insecticide has been
in a large measure responsible for the bumper crop of rice in 1955 in
Japan. In a way useful as it is, parathion also has its short-coming,
namely, to human beings, the estimated number of its victims during
past five years is said to be over 6,000. Consequently, many studies have
so far been made on the poisoning of alkylphosphate compounds, and on
the basis of numerous clinical observations5 , the present authors6 estab-
lished a standard atropine treatment, by which many patients of parathion
poisoning have been saved in Japan. However, it is to be regretted that
atropine is not omnipotent.
Recently Prof. 1. B. WILSON of Columbia University, introduced 2-
pyridine aldoxime methiodide (PAM) as a specific reactivator of acetyl-
cholinesterase inactivated by alkylphosphate. PAM successfully activated
the inhibited acetylcholinesterase in vitro12, and hundreds of mice injected
with lethal doses of alkylphophate were spared of their lives by PAM
injection8 • But the acting mechanim of PAM in vivo, has not yet been
persued in full detail and especially so with its clinical effect15•
The present paper is intended to report experiments in laboratory
rabbits and the therapeutic effects of PAM on the patients suffering from
acute parathion poisoning.
Method
PAM used is a yellow rhombic crystal with a melting point at 219"C.
It is soluble in water 5% at maximum and practically insoluble in alcohol.
The structural formula assigned to PAM is shown in Fig.!.
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PAM itself has no power to hydrolyse acetylcholine in vitro. The
LDoo (mg./kg.) of PAM on mice was estimated as 136±6 Band 209 (187-
233)14 in the case of intraperitoneal injection, 140 (125-157)14 subcuta-
neous injection. In the present study, 5% PAM solution in water was
used.
Blood cholinesterase activity was assayed manometrically with TA-
MAl'S modificationtl of AMMON'S method1 at 38 c C in a medium containing
0.124M NaCl, 0.025M NaHC03, 0.0025M KCl, 0.0018M CaCh and 0.025M
or 0.0025M (the former for human serum cholinesterase and the latter for
the others) acetylcholine as substrate. The estimation of cholinesterase
activity was based on CO2 volume produced during 30 minutes after the
addition of substrate.
The determination of mucoprotein and active SH-radical of protein
were performed polarographically.
Laboratory Experiments
White male rabbits each weighing about 2kg. were used. Introduction
of PAM itself had no influence on the general appearance and blood cho-
linesterase in rabbits.
A subcutaneous injection of 10 mg./kg. of parathion emulsion (appro-
ximate LD,-,o) caused the inhibition of blood cholinesterase and presented
the symptom of poisoning such as muscular fasciculation, salivation and
noisy respiration.
An intravenous injection of PAM in the rabbits priorly injected with
parathion emulsion presented a striking reactivation of blood cholinest-
erase and the disappearance of symptoms in a short period of time.
Twenty four hours after the parathion injection, however, this rabbit
died owing to the reinhibition of blood cholinesterase, proving the effect
of PAM to be only transient (Fig. 2).
Repeated injections of relatively large dose of PAM presented the
maintenance of blood cholinesterase in an activated state, and no symp-
toms could be observed (Fig. 3), prolonging the life of rabbit even in
as high a dosage as 50 mg./kg. parathion injection. In this case, the first
PAM injection was the most effective in reactivating cholinesterase but
later injections gradually lost their effectiveness (Fig. 4).
In these experiments, PAM was injected in the process of cholineste-
rase inhibition by parathion and the effect was observable only transient-
ly; but in the cases receiving PAM in the course of natural recovery of
cholinesterase activity the cholinesterase reinhibition appearing later was
slight (Fig. 5). In both subcutaneous injection (Fig. 6) and oral adminis-
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tration (Fig. 7), PAM demonstrated itself just as effective. Oral adminis-
tration of PAM could likewise protect the cholinesterase inhibiting action
of parathion (Figs. 8, 9).
Case Report
Parathion poisoning is divided into four stages, namely, serious,
moderate, slight, and latent, by the present authors6). This classification
is now being used widely in Japan.
Case 1: A serious case, admitted Sept. 2, 1956.
A 17·year old high school boy, sprayed a rice field with a parathion
solution. On the next day he became ill in the evening. After receiving
20·ampule injection of atropine, 0.5 mg. each, the patient was brought to
our clinic 3 hours after the onset of symptom. He then was in the con-
valescent stage.
An intravenous injection of 0.1 g. PAM produced neither changes of
symptoms nor toxic effect, but the transient and slight recovery of red
blood cell cholinesterase (Fig. 10). This boy improved 6 hours after the
onset of poisoning.
Case 2: A serious case, admitted Sept. 2, 1956.
A 24·year old farmer, sprayed a rice field with a parathion solution.
In the afternoon of the day after this work, he fell ill complaining of
nausea, vomiting, abdominal cramps, diarrhea, profuse sweating, sali-
vation, involuntary micturition, muscular fasciculation and coma.
He was given ten intravenous injections of 0.1 g. PAM each during
the periods of 3 and a half hours. By the time of the last PAM injection,
all the symptoms had disappeared and no toxic effect of PAM itself could
be discernible. In this case, the recovery of blood cholinesterase activity
were impressive, in that red cell cholinesterase being reactivated by
degrees, reached over normal. On the contrary, serum cholinesterase
activity moved slightly, though it only required half the time for the
recovery to the normal level compared with the time required by the un-
treated (Fig. 11).
Case 3: A serious case, admitted Sept. 3, 1956.
This 24 year old farmer had been engaged in spraying a rice field
with a parathion solution. On the 3rd day he fell ill and was admitted to
our clinic. He then complained of dizziness, nausea, vomiting, headache,
salivation, profuse sweating and slight muscular fasciculation.
On admission 0.5 g. PAM was injected intravenously without any
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toxic sign; and therefore, the further injection of 004 g. PAM was made
10 minutes later. Immediately after the second injection, all his com-
plaints disappeared. Complete recovery of red cell cholinesterase took
place 40 minutes after the last PAM injection, though serum cholin-
esterase activity made a very slight recovery, and returning to normal in
15 days (Fig. 12).
Case 4: A serious case, admitted Sept. 6, 1956.
A farmer, age 28. This case is supposed to be the first of parathion
poisoning ideally treated with PAM, and is, therefore, presented in detail.
History: Engaged in spraying a rice field with 0.1 % parathion solu-
tion. At 1: 30 p. m. on the 3rd day of the work, he had dizziness, profuse
sweating, salivation and tightness of the chest, but continued to work
until 3: 00 p. m., when nausea and vomiting began. Shortly thereafter,
he went home and thoroughly washed himself. At 4: 00 p. m. he was at-
tacked by severe dizziness, slurred speech, blurring of vision, and coma.
After the injection of 3 ampules of atropine, he was brought to our clinic
at 6: 30 p. m.
Physical Examination: Well developed male, seriously ill and un-
responsive. His respiration was slow and seemed difficult. The pulse
rate was 130 per minute, and blood pressure 170/110 mm. Hg. The body
temperature 37.5°C. Muscular fasciculation was very marked and gener-
alized. He was no longer sweating but had excessive salivation. The
pupils were pinpoint in size, reacting scarcely to light. The cardiac
dullness was slightly enlarged with the heart sounds powerful and good.
The lung and abdomen were normal. Tendon reflexes of the extremities
were absent.
Laboratory Findings: Cholinesterase activity of red blood cell was
28.9 ml. CO:?, approximately 13 % of normal, and that of serum 4.9 ml. CO2,
only 0.6 % of normal. Serum mucoprotein was 38.8 % and SH-radical ac-
tivity of serum protein 47.5 % of normal. Leucocyte count was 19,900 per
cubic millimeter, with 87 % polymorphonuclear cells, 10 % lymphocytes
and 3 % monocytes. Eosinophiles were absent. Hemoglobin was 12.6
g./dl., with 5,170,000 erythrocytes per cubic millimeter. Urine definitely
contained sugar, slight urobilinogen and 133.8 mcg/dl. of p-nitrophenol.
Blood sugar 149 mg./ dl. Cephalin cholesterol flocculation, Takata's
test, icterus index and other tests on seru.m were normal. Electrocardio-
gram showed right bundle-branch block, probably related with poisoning.
Course and Treatment: At 6: 37 p. m. 7 minutes after admission
he was given 19. of PAM intravenously. The muscular fasciculations
diminished instantly except in certain parts of the breast and legs and he
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was awake and responsive.
At 6: 41 p. m. blood pressure was 158/80mm. Hg. Respiration quieted
down. At 6: 58 p. m. 21 minutes after PAM injection, the muscular
fasciculation disappeared completely and no symptoms could then be
found.
The hourly changes of the blood cholinesterase values are given in
Fig. 13. The activity of erythrocyte cholinesterase returned to normal
within 10 minutes of PAM injection, serum cholinesterase reactivated
transiently, but returned to normal earlier than that of untreated case.
The changes of mucoprotein and protein·SH-radical activity ofc;erum
are given in Fig. 14. Both show the similar changes as those of serum
cholinesterase. In other cases, serum mucoprotein and protein-SH-radical
activity of serum are similar to this case.
Case 5: A serious case, visited Sept. 10, 1956.
A 37 year-old farmer, who had consulted a doctor about a week before,
visited our clinic on the 8th day of acute parathion poisoning. He was
then complaining only of slight headache with no physical findings. Blood
cholinesterase activity was also on the way to recovery.
Intravenous injection of 1 g. of PAM was immediately given, but he
felt discomfort less than one minute and showed no other toxic symptoms.
Blood cholinesterase value showed little change (Fig. 15).
Discussion
1. The administration of PAM dispersed promptly the symptom of
poisoning:
The effect was more remarkable in the clinical experiments than in
the animal experiments.
In the case 1, the clinical improvement was hardly noticeable due
probably to a small dosage of PAM. In the case 2, the effect was some
what obscure and as for the cases 3 and 4, to whom sufficient dosage of
PAM had been administered in a single dose, dramatical effects were ob-
served at the instance of the injection; recovery of a clear consciousness,
disappearance of mascular fasciculations, an improvement of respiratory
function and so on. In these cases, the dosage of atropine was not large
enough to affect the symptoms, except the case 1 who was cured by atro-
phine rather than by PAM.
The treatment with atropine, which has so far been considered to be
an effective medicament, can disperse only a portion of poisoning symp-
toms, and can not affect symptoms such as mascular fasciculation. Be-
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sides, it has its short-coming in that as it requires a large dosage to make
it effective, there naturally arise unpleasant side-effects.
With the administration of PAM, however, all the symptoms could
be made to disappear and there arose no unpleasant side effects. From
this fact it may safely be said that PAM is the specific and the causal
therapeutics in the treatment of alkylphosphate poisoning.
2. Cholinesterase activity of red blood cell was instantly and com-
pletely recovered, and that of serum gradually:
In only ten minutes after PAM injection, cholinesterase activity of
red blood cell recovered to normal as observed in the case 4. Such a
phenomenon could not be expected so far. The activity then decreased to
some extent but remained within the normal limit in human. This finding
is quite surprising since without PAM administration the recovery of
cholinesterase activity generally takes quite a long period, a month or
more in serious cases and since it is not in any way affected by atropine
treatment. The recovery rate of serum cholinesterase activity, however,
was slower and transient, but even in such a case, it regained the normal
value in about a half of the length of time as compared with the untreated.
There are two types of cholinesterase, true or acetylcholinesterase
and non-specific or pseudocholinesterase. In human, the former is con-
tained in the nervous tissue and red blood cells, and is regarded to act on
the neurohumoral transmission. The latter is contained in serum, and is
considered to have essentially no funciton on the nE>urohumoral transmis-
sion but related closely to the liver function. In the rabbit, serum cholin-
esterase belongs to acetylcholinesterase. Thus this fact may make it
comprehensible why the values of both serum and red cells in the rabbit
cholinesterase behave alike while they do not in human cholinesterase,
and why all the symptoms do disappear without restoration of serum cho-
linesterase in patients..
From these results, it is obvious that the main effect produced by
the administration of PAM is the restoring of the activity of acetylcholin-
esterase and the effect on pseudocholinesterase is but complimentary. As
the cholinesterase of the nervous tissue is of true type, PAM is remark-
ably effective in the treatment of alkylphosphate poisoning.
KEWITZ and WILSON rightly assumed that PAM probably reactivate
acetylcholinesterase in vivo, making their assumption on the basis of their
in vitro experiments in which it has been found that PAM is a much
poorer reactivator of human serum cholinesterase8 •
At the present the definite diagnosis of alkylphosphate poisoning is
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being made mainly on the lowering of serum cholinesterase (pseudocholin-
esterase) value besides physical examinations. It has been generally
accepted that the degree of the damage in vivo caused by alkylphosphate
poisoning may be estimated more exactly by measuring the acetylcholin-
esterase. We would venture to recommend rather the measuring of serum
cholinesterase activity in making qualitative and quantitative analysis of
alkylphosphate poisoning, because of the complexity in the determination
of the activity of red cell cholinesterase to be used in actual practice and
because of a relatively long time required in becoming proficient in the
manipulation. Mydriasis, the most standard symptom of the diagnosis, has
almost lost its significance in our clinic, as atropine has come to be widely
used in the treatment and nearly all the patients are sent to our clinic
after the premedication with atropine. In future when PAM treatment
attains a universal recognition, it might be possible to diagnose the poi-
soning after PAM administration basing not on the cholinesterase activity
of red blood cell but on that of serum.
3. The behavior of serum mucoprotein varies in direct proportion to
the activity of serum cholinesterase and the behavior of active protein SH
radical of serum nearly coincides with that of serum mucoprotein:
Changes other than those of cholinesterase activities in parathion
poisoning have been recently observed by the present authors with muco-
protein and active protein-SH·radical in serum; and the findings of which
are arousing a keen interest in Japan4 • With PAM administration, the
changes of serum mucoprotein are similar to those of serum cholinesterase,
and those of active protein-SH-radical are also similar but less remakable.
4. An intravenous injection of 1 g. PAM is generally sufficient but
the dosage may be increased if necessary:
Considering the acting mechanisms of PAM and parathion, one mole-
cule of parathion may be thought to combine with one molecule of PAM.
As the molecular weight of both substances are nearly equal, it will be
sufficient to give PAM in the same proportion of dosage to the amount
of parathion, but from our experiments, it seems more advisable to give
larger dosage.
As in the cases 2, 3 and 4, an intravenous injection of 1 g. PAM
was sufficient to disperse the clinical symptom and restore the cholineste-
rase activity of red blood cell. After the administration of PAM, a
transient decrease of the activity of cholinesterase of red blood cell is apt
to occur, and so in serious cases there may be a possibility of relaps
of the symptom together with the reinhibition of cholinesterase. But from
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our experiences, it is found that if the patient survived for as long as 12-24
hours after the onset of symptoms, he generally recovered spontaneously.
From these facts, 1 g. dosage may be sufficient and if needed one
or two more grams of PAM may be given.
Now we are considering of giving larger doses of PAM in order to
treat parathion poisoning more effectively as we believe that this seems
to be especially necessary with the case where larger amount of parathion
is taken as in suicide cases.
Because of the time element involved in the treatment of parathion
poisoning, PAM was administered intravenously, but subcutaneous route
may be employed as well. Oral administration may be effective but not
practical, for parathion poisoning, even in its mild form, is usually ac-
companied by nausea and vomiting.
5. No ill effect has been encountered in the PAM administration:
The ill effect of any new drug should be seriously taken into con-
sideration. In laboratory mice experiment, the intravenous LD50 of PAM
was found to be 140 mg./kg. (125-156), and this dosage turned out to be
sufficient in the actual application.
Some patients as in the cases of 1 and 2, receiving a smaller dosage
of PAM, had vomiting, but it seemed to be the symptom caused by para-
thion poisoning rather than the drug itself as no such ill effect was
found in the patients like cases 3 and 4, given larger doses of PAM. The
patient like case 5, receiving rather rapid PAM intravenous injections,
complained of a slight discomfort lasting only one minute.
Abnormalities of both blood picture and liver function were not ob-
served. No pains or local changes of vein and skin at the site of the
injection appeared. As far as PAM is concerned, these facts seem to
assure that there is no danger of ill effect in the conventional administra-
tion now in use and even in case of larger dosage.
6. PAM had no influence on the cholinesterase activity of normal
blood:
After the administration of PAM, the blood cholinesterase activity
in normal rabbits remained within its normal range and this was also the
case with that of man, case 5. WIRTH13 and JENSEN7 have reported that
most of phosphoric acid derived from parathion was excreted within 1-3
days and later only in a small amount. Judging from these facts, it might
be assumed that PAM has the activity only against the phosphorylated
cholinesterase (Fig. 16).
7. PAM is expected to be used as a preventive agent to alkylphos-
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phate poisoning:
As already mentioned, PAM exhibits no effect when intravenously
administered in small doses for a prophylactic purpose. This fact is
construed to be due to the possibility of PAM being promptly excreted or
inactivated. On the other hand, PAM may be assumed to be a preventive
agent of the lowering of cholinesterase activity in rabbit by oral admi-
nistration in a large dosage. In man it is expected to be more effective
than in the rabbit as we have seen in its therapeutic uses.
Hitherto, alkylphosphate poisoning has mainly been treated by at-
ropine, but now it should be replaced by PAM. PAM as a causal thera-
peutic agent to not only the alkylphosphate but also the nerve gas poison-
ings, we might expect a rapid progress of the study on enzyme mecha-
nisms.
Summary
We have designed to apply 2-pyridine aldoxime methiodide(PAM),
considered to be a cholinesterase reactivator in vitro, both tow laboratory
rabbits poisoned by parathion and to the patients of parathion poisoning,
and obtained the following results:
1. With administration of PAM, a prompt and complete dispersion
of symptoms of the poisoning can be realized.
2. Cholinesterase activity of red blood cell has instantly and com-
pletely recovered, and that of serum transiently.
3. The amount of serum mucoprotein and the activity of active pro-
tein·SH-radical of serum varied in direct proportion to the activity of
serum cholinesterase.
4. Generally, an intravenous injection of 1 g. PAM is sufficient even
in the severe case and it may be increased when necessary.
5. The ill effect has not been encountered in the PAM administra-
tion.
6. PAM exerts no influence on the cholinesterase activity of normal
blood.
7. PAM is expected to play an important role as a prophylactic agent
of alkylphosphate poisoning.
From these results it seems clear that PAM is a specific and effective
antidote against alkylphosphate intoxication.
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Explanations of Figures
Fig.!. Structural formula and crystal of 2-pyridine aldoxime methiodide (PAM).Fig. 2. Rabbit No. 1. Blood cholinesterase acitivity in comparison with that of
untreated case (with PAM). Transitory recovery of cholinesterase activity by PAMinjection, i. v.
Fig. 3. Rabbit, No. 2. Blood cholinesterase activity compared with that of the
untreated. Continuous reactivation of cholinesterase by repeated PAM injections, i. v.Fig. 4. Rabbit, No. 3. Blood cholinesterse activity. Prolonged life and recovery of
cholinesterase by repeated intravenous injections of large doses of PAM even in the
case injected with 50 mg/kg parathion, s. c.
Fig. 5. Rabbit, No. 4. Blood cholinesterase in comparison with that of untreated
case. Little reinhibition of cholinesterase activity by an intravenous injection of PAM
at the time of the cholinesterase activity while recovering.
Fig. 6. Rabbit, No. 5. The comparison between blood cholinesterase activity andthat of the untreated. Transitory reactivation of cholinesterase by a single subcuta-
neous injection of PAM.
Fig. 7. Rabbit, No. 6. Blood cholinesterase activity compared with that of un-treated case. Slower reactivation and reinhibition of cholinesterase by an oral PAM
administration.
Fig. 8. Rabbit, No. 7. Blood cholinesterase in comparison with that of untreated
case. Slight cholinesterase inhibition by an oral application of PAM 30 minutes beforeparathion injection.
Eig. 9. Rabbit, No. 8. Blood cholinesterase in comparison with that of untreated
case. Slight and slow inhibition of cholinesterase by an oral PAM application simul-taneous with parathion injection.
Fig. 10. Case 1. Serious case. Blood cholinesterase compared with untreated case.Transitory slight recovery of red blood cell cholinesterase by an intravenous injection
of O.lg. of PAM.
Fig. 11. Case 2. Serious case. Blood cholinesterase in comparison with untreated
case. Recovery of red blood cell cholinesterase to normal step by step by repeatedPAM injections, i.v. a total of O.lg.
Fig. 12. Case 3. Serious case. Blood cholinesterase activity in comparison withthat of untreated case. Instantaneous recovery of red cell cholinesterase to normal,
and slight recovery of serum cholinesterase by PAM injections, i. v., total of 0.9 g.Fig. 13. Case 4. Serious case. Blood cholinesterase activity in comparison with that
of untreated case. Instant and complete recovery of red cell cholinesterase and tran-
sient recovery of serum cholinsterase by a single 1.0 g. PAM injection, i. v.
Fig. 14. Case 4. Serious case. Serum mucoprotein and serum protein SH radical
activity. Neary similar changes to serum cholinesterase activity.
Fig. 15. Case 5. Serious case. On 8th day of the onset of poisoning. Blood cho··linesterase by an intravenous injection of 1.0 g. of PAM, i. v.
Fig. 16. A schematic diagram of the inhibition of cholinesterase by parathion andthe reactivation of cholinesterase by PAM.
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